Recent News

• 04.24.2025 - Employee Spotlight: Shirin Azizi
• 04.23.2025 - Penumbra, Inc. Reports First Quarter 2025 Financial Results
• 04.23.2025 - Announcing RED® 72 SILVER LABEL — Now Featuring Penumbra’s Latest Engineering Enhancements Designed for Seamless Navigation
• 04.03.2025 - Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025
• 04.02.2025 - Lightning Bolt® Technology Restores Blood Flow in Rutherford 2b Limb Ischemia
• 04.02.2025 - Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

Recent Filings

• 04.23.2025 - EX-99.1 EX-99.1
• 04.23.2025 - 8-K Current report
• 04.23.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - ARS Annual Report to Security Holders
• 04.16.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.16.2025 - 144 Report of proposed sale of securities
• 04.16.2025 - DEF 14A Other definitive proxy statements